JLM-BioCity Innovations - JLM-BioCity

Oramed Granted NASH Patent in Europe

April 7, 2022

Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that the European Patent Office

Synthetic Biology Startup Seevix Material Sciences Starts Global Marketing Campaign for its Tissue Engineering Scaffold

April 7, 2022

HUMAN TISSUE REGENERATION IS SEEVIX’S ULTIMATE GOAL Seevix Material Sciences Ltd. is a privately-held biotech company producing high-strength SVX™, a state-of-the-art biopolymer material, inspired by

BiondVax Signs Expanded Agreement with Max Planck Society to Develop Nanosized Antibody Therapies

April 5, 2022

BiondVax Pharmaceuticals Ltd. (Nasdaq:BVXV), a Jerusalem based biopharmaceutical company focused on developing, manufacturing, and commercializing innovative products for the prevention and treatment of infectious diseases

BactoByte Develops Life-Saving Blood Diagnostic with Quick-1- Hour Turnaround

March 29, 2022

BactoByte is developing a conceptually new laboratory system that will process a line of assays, delivering clinical-grade results in medical (blood, urine, swabs, spinal fluid),

Terrapeutics Signs Agreement with HIPS to Co-Develop Novel Antibiotics to Treat Incurable Cancers

March 28, 2022

Terrapeutics Pharma (“Terrapeutics”) and the Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) are pleased to announce that they have reached a cooperation agreement to co-develop novel

Neurogenesis & Hadassah Announce Exciting Results from their Multiple Sclerosis Phase 2 Study

March 14, 2022

Eight of 15 MLS patients who receive NG-01 therapy as spinal injection see better disability scores; inventors say therapy may ‘dramatically improve’ patients’ lives. See

Gyntools Begins Pilot Program for Vaginitis Screening for Women of IDF

March 1, 2022

Gyntools is about to undertake a pilot study with the Israel Defense Force (IDF) in order to screen for Vaginitis in women who are serving

Ascento Medical & Hadassah Medical Join Forces to establish Innovative Alzheimers/Dementia Clinic

March 1, 2022

Ascento Medical Ltd has just announced on January 23, 2002, their partnership with Hadassah Medical in order to develop clinics to diagnose, treat, and prevent

EU Tech Fund Invests in Betalin Therapeutics developing Novel Therapies for Diabetes

February 22, 2022

The European Innovation Council (EIC) Fund has decided to make a direct equity investment in Jerusalem-based Betalin Therapeutics in the amount of 500,000 Euros. The

More JLM-BioCity events coming soon…

Alexander Naslednikov

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

-Alexander Naslednikov, Founder and CEO, Med.me

Tal Or

One of the best meetups organizations and a very important source of information and connections for startups.

-Tal Or, Co-Founder, ATLASense Biomed Ltd.

Hemda Idel

Very informative and eye-opening event. Thank you for the great hospitality.

– Hemda Idel, founder, SLEEP ASAP

Aviv Marom

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

-Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

Aurélie Schwarzbach

Such an interesting lecture and great people attending!

– Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

Zeev Malyutin

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

– Zeev Malyutin, Protein Department Head, Merck KGaA

Gideon Silberman

Excellent event. Good speakers, interesting audience. Well done!

– Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

Immanuel Lerner

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

– Immanuel Lerner CEO, Pepticom

Dror Chevion

JLM-BioCity’s events are well organized with a professional approach. You can feel a “homey” atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

– Dror Chevion CEO, Concenter BioPharma

Ian Solomon

The JLM BioCity networking events on Zoom keeps getting better. For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

-Ian Solomon CTO, OmnySense Ltd.

Moshe Lebowitz

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

– Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.